Delivery Order SPE2DB24D9228-SPE2DB24FATFU
Award Date
9/19/24
Potential Completion Date
10/10/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract, valued at $11,840.00, has an ultimate completion date of September 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to $499,999,999, which runs through...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $29,048.00, is for the delivery of Mirena 52 mg systems to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows DLA to issue orders...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The $11,840.00 firm fixed-price contract has a period of performance through May 31, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The contract has a completion date of February 13, 2024 and a potential value of $2,960.00. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of medical supplies and pharmaceuticals to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of 4,562,293,327 units of Mirena 52 mg systems. The award, valued at $29,048.00, has an ultimate completion date of October 11, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract has a ceiling value of $15,623.10 and a period of performance through February 4, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter...
The Defense Logistics Agency (DLA) awarded a $59,200.00 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Mirena 52 mg systems. The contract, which has a completion date of January 31, 2024, is not associated with a larger contract vehicle. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic prescription and over-the-counter drug supplies to the federal government,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,776.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of Mirena 52 mg systems to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,207.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of Mirena 52 mg systems. This delivery order was issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The contract covers a wide range of pharmaceutical products, including branded and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $5,920.00, to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Mirena 52 mg intrauterine contraceptive systems. This award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025, to supply a broad range of pharmaceutical products to military medical facilities worldwide. The...